ANI Pharmaceuticals Initiated at Outperform by Leerink Partners
Leerink Partners Initiates ANI Pharmaceuticals(ANIP.US) With Buy Rating, Announces Target Price $80
Intrauterine Devices Market Report Forecasts and Company Analysis 2024-2032, Profiles of AbbVie, Bayer, Teva Pharmaceuticals, ANI Pharmaceuticals, Mylan, CooperSurgical. and DKT International
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Shareholders Respectable 19% CAGR Over 3 Years, Surging 5.9% in the Last Week Alone
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}